6/28/2018 9:11:24 AM
RedHill Biopharma Enters Co-promotion Agreement With Napo
9/29/2017 1:35:33 PM
Jaguar Health Prices $4.25 Mlon Public Offering Of Common Stock
9/28/2017 9:14:15 AM
Jaguar Subsidiary Napo Files CMC Supplement With FDA For Sample-Size Bottles Of Mytesi, Napo’s FDA-Approved Human Drug
9/18/2017 8:16:58 AM
Jaguar Health Intends To Offer And Sell Shares Of Its Common Stock
6/29/2017 6:01:22 AM
Hercules Capital Announces Addl Portfolio Company Liquidity Events; Portfolio Companies Currently In IPO Registration
6/5/2017 9:05:18 AM
Jaguar Animal, Napo Announce Filing Of Two Orphan Drug Designation Applications With FDA For Mytesi
5/10/2017 9:06:10 AM
Jaguar Animal Health, Napo Appoint Pravin Chaturvedi As Chair Of Combined Company’s Scientific Advisory Board
4/17/2017 6:02:42 AM
Hercules Capital Reports Unscheduled Principal Repayments “early Pay-offs” Of $100.3 Mln For Q1
3/31/2017 9:03:41 AM
Jaguar Animal Health And Napo Pharma Enter Definitive Merger Agreement
2/28/2017 9:05:14 AM
Napo Pharma Signs Agreement With Alamo Pharma Services To Launch National Sales Force For Mytesi
2/23/2017 4:14:29 PM
Hercules Q4 Distributable Net Operating Income $34.5 Mln Or $0.45 Per Share